EWS has a 10-year history and experience in the design, manufacture, service and supply of water treatment, water purification and waste water recovery systems in the healthcare and industrial sectors with a turnover of more than GBP5m.

The healthcare sector represents more than 50% of EWS’ revenues, with EWS’ product portfolio including HTM2030 compliant reverse osmosis systems serving sterile service departments in over 30 hospitals throughout the UK.

Amplio Group will combine EWS with Puresep Holdings that it acquired in July 2010, to more than double Amplio Filtration’s share in the UK’s food and beverage, healthcare and industrial treatment water industry in the next three years, thereby procuring a 25% share of the UK market.

Amplio Filtration head Andrea Davi said that the addition of EWS is particularly exciting as it extends the company’s customer footprint into the non-discretionary sector of water management in hospitals across the UK, providing us with high quality secure income streams.

“We are especially excited about the synergies between EWS and Puresep, which are already bearing fruit through cross-selling of the water treatment technology and service offer to a broader customer base,” Davi said.